Skip to main content

Table 4 Correlation between plasma IgG and HbA1c levels in T2D patients before and after glucose-lowering treatment

From: Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance

Antigen

Before treatment

3-month treatment

6-month treatment

r

p a

r

p b

r

p c

IL1α

-0.024

0.762

-0.005

0.978

-0.477

0.039

IL1β

-0.011

0.888

-0.030

0.875

-0.278

0.250

IL6

-0.052

0.517

-0.191

0.304

-0.519

0.023

IL8

-0.089

0.266

-0.239

0.196

-0.400

0.090

TNF-α

0.069

0.384

-0.129

0.489

-0.137

0.576

  1. adf=157; bdf=29; cdf=17